Ingfei Chen is a writer and editor in Northern California who likes telling stories about medicine, science and the environment. Her articles have published in The New York Times, Science, KQED Mindshift, Scientific American and Smithsonian, among others.
Ingfei Chen
Freelance writer
From this contributor
What baby siblings can teach us about autism
Studies of infants at risk for autism have not yielded a test to predict who will eventually be diagnosed. But they have transformed our understanding of the condition.
The gene hunters
Criss-crossing the globe on a quest for unusual DNA, researchers have discovered a rare mutation that promises insights into both epilepsy and autism — and points to a treatment.
Wide awake: Why children with autism struggle with sleep
Half of children who have autism have trouble falling or staying asleep, which may make their symptoms worse. Scientists are just beginning to explore what goes wrong in the midnight hour.
Wide awake: Why children with autism struggle with sleep
By
Ingfei Chen
7 October 2015 | 16 min read
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
By
Calli McMurray
6 September 2024 | 5 min read
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
By
Rachel Zamzow
5 September 2024 | 5 min listen
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
By
Olivia Gieger
4 September 2024 | 6 min read